NO20052254L - Regulering av type II collagen-genekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler - Google Patents

Regulering av type II collagen-genekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler

Info

Publication number
NO20052254L
NO20052254L NO20052254A NO20052254A NO20052254L NO 20052254 L NO20052254 L NO 20052254L NO 20052254 A NO20052254 A NO 20052254A NO 20052254 A NO20052254 A NO 20052254A NO 20052254 L NO20052254 L NO 20052254L
Authority
NO
Norway
Prior art keywords
specific
gene expression
selective
cartilage
type
Prior art date
Application number
NO20052254A
Other languages
English (en)
Other versions
NO20052254D0 (no
Inventor
Carl T Brighton
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO20052254D0 publication Critical patent/NO20052254D0/no
Publication of NO20052254L publication Critical patent/NO20052254L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Fremgangsmåter og anordninger for regulering av type-I1-collagen-genekspresjon i bruskceller via påføring av spesifikke og selektive felt generert ved spesifikke og selektive elektriske og elektromagnetiske signaler i behandling av syk eller skadet leddbrusk. Ved genekspresjon menes oppregulering eller nedregulering av prosessen hvor spesifikke deler (gener) av det humane genomet (DNA) er transkribert til mRNA og deretter translatert til protein. Fremgangsmåter og anordninger er tilveiebrakt for den målrettete behandlingen av skadet eller sykt bruskvev som inkluderer å generere spesifikke og selektive elektriske og elektromagnetiske signaler som genererer spesifikke og selektive felt optimalisert for type-II-collagen-genekspresjon og å eksponere bruskvev for de spesifikke og selektive feltene generert ved spesifikke og selektive signaler for å regulere type-II-collagen-genekspresjon i slikt bruskvev. De resulterende fremgangsmåtene og anordningene er nyttige for den målrettete behandlingen av osteoartritt, reumatoid artritt, bruskskade og bruskdefekter.
NO20052254A 2002-10-09 2005-05-06 Regulering av type II collagen-genekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler NO20052254L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/267,708 US6919205B2 (en) 2000-02-23 2002-10-09 Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals
PCT/US2003/031793 WO2004033644A2 (en) 2002-10-09 2003-10-07 Regulation of type ii collagen gene expression using specific and selective electrical and electromagnetic signals

Publications (2)

Publication Number Publication Date
NO20052254D0 NO20052254D0 (no) 2005-05-06
NO20052254L true NO20052254L (no) 2005-07-04

Family

ID=32068429

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052254A NO20052254L (no) 2002-10-09 2005-05-06 Regulering av type II collagen-genekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler

Country Status (16)

Country Link
US (1) US6919205B2 (no)
EP (1) EP1575475B1 (no)
JP (1) JP2006501853A (no)
KR (1) KR20050056233A (no)
CN (1) CN1703184A (no)
AU (1) AU2003279184A1 (no)
BR (1) BR0315241A (no)
CA (1) CA2501554C (no)
CR (1) CR7789A (no)
EG (1) EG23918A (no)
ES (1) ES2593307T3 (no)
MX (1) MXPA05003785A (no)
NO (1) NO20052254L (no)
NZ (1) NZ539833A (no)
WO (1) WO2004033644A2 (no)
ZA (1) ZA200503422B (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (ja) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． 電気的筋肉制御装置
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US7981611B2 (en) * 2000-02-23 2011-07-19 The Trustees Of The University Of Pennsylvania Regulation of fibroblastic growth factor-2 (FGF-2) gene expression in living cells with the application of specific and selective electric and electromagnetic fields
US8313908B2 (en) 2000-02-23 2012-11-20 The Trustees Of The University Of Pennsylvania Regulation of stem cell gene production with specific and selective electric and electromagnetic fields
US7429471B2 (en) * 2000-02-23 2008-09-30 The Trustees Of The University Of Pennsylvania Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
US7374916B2 (en) 2000-02-23 2008-05-20 The Trustees Of The University Of Pennsylvania Regulation of aggrecan gene expression using specific and selective electrical and electromagnetic signals
US7465546B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
US7465566B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7022506B2 (en) * 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
US7840262B2 (en) 2003-03-10 2010-11-23 Impulse Dynamics Nv Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
GB2400316A (en) * 2003-04-10 2004-10-13 Richard Markoll Electromagnetic stimulation in patients with osteoporosis
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US20110112352A1 (en) * 2003-12-05 2011-05-12 Pilla Arthur A Apparatus and method for electromagnetic treatment
US10350428B2 (en) 2014-11-04 2019-07-16 Endonovo Therapetics, Inc. Method and apparatus for electromagnetic treatment of living systems
US9440089B2 (en) 2003-12-05 2016-09-13 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological injury or condition caused by a stroke
US9427598B2 (en) 2010-10-01 2016-08-30 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic treatment of head, cerebral and neural injury in animals and humans
US8961385B2 (en) 2003-12-05 2015-02-24 Ivivi Health Sciences, Llc Devices and method for treatment of degenerative joint diseases with electromagnetic fields
US7744524B2 (en) * 2003-12-05 2010-06-29 Ivivi Health Sciences, Llc Apparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules
US9433797B2 (en) 2003-12-05 2016-09-06 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurodegenerative conditions
US20130218235A9 (en) * 2005-03-07 2013-08-22 Arthur A. Pilla Excessive fibrous capsule formation and capsular contracture apparatus and method for using same
US9415233B2 (en) 2003-12-05 2016-08-16 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological pain
US9656096B2 (en) 2003-12-05 2017-05-23 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic enhancement of biochemical signaling pathways for therapeutics and prophylaxis in plants, animals and humans
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
WO2006119467A2 (en) 2005-05-04 2006-11-09 Impulse Dynamics Nv Protein activity modification
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
BRPI0509444A (pt) 2004-04-19 2007-09-04 Ivivi Technologies Inc método para o tratamento eletromagnético de tecidos e células vivos através da intensificação da angiogênese e da neovascularização, aparelho de tratamento eletromagnético e dispositivo gerador de sinais eletromagnéticos
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
CA2594673A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
US7981065B2 (en) * 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7279110B2 (en) * 2004-12-27 2007-10-09 Asml Holding N.V. Method and apparatus for creating a phase step in mirrors used in spatial light modulator arrays
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
US7840272B2 (en) 2005-06-03 2010-11-23 Medrelief Inc. Methods for modulating osteochondral development using bioelectrical stimulation
US7774057B2 (en) * 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
US20090018613A1 (en) * 2006-08-02 2009-01-15 Genestim, Llc Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
CN101891803B (zh) * 2010-07-15 2012-09-05 北京大学第三医院 一种软骨亲和多肽序列、其筛选方法及应用
US8795147B1 (en) 2010-10-07 2014-08-05 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Modifying the genetic regulation of bone and cartilage cells and associated tissue by EMF stimulation fields and uses thereof
US9896681B2 (en) 2010-10-07 2018-02-20 The United States Of America As Represented By The National Aeronautics And Space Administration Genetic regulation of bone and cells by electromagnetic stimulation fields and uses thereof
US8343027B1 (en) 2012-01-30 2013-01-01 Ivivi Health Sciences, Llc Methods and devices for providing electromagnetic treatment in the presence of a metal-containing implant
EP3131628A4 (en) 2014-04-16 2017-11-22 Ivivi Health Sciences, LLC A two-part pulsed electromagnetic field applicator for application of therapeutic energy
EP3481495A4 (en) * 2016-07-07 2020-04-29 Venus Concept Ltd APPARATUS FOR AESTHETIC USEFUL FOR INCREASING SKIN REGENERATION AND RELATED METHODS
WO2018089795A1 (en) 2016-11-10 2018-05-17 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues
CN110604098B (zh) * 2019-09-23 2021-09-07 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 一种类风湿关节炎合并间质性肺病动物模型的构建方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4509520A (en) * 1982-02-22 1985-04-09 Biolectron, Inc. Electrical stimulating apparatus
US5269746A (en) * 1982-12-20 1993-12-14 Jacobson Jerry I Therapeutic treatment of mammals for epilepsy and Parkinson's disease
US4535775A (en) * 1983-02-10 1985-08-20 Biolectron, Inc. Method for treatment of non-union bone fractures by non-invasive electrical stimulation
IT1159024B (it) * 1983-06-02 1987-02-25 Ruggero Cadossi Metodo e dispositivo per il trattamento di tessuti e cellule viventi mediante campi elettromagnetici pulsanti
US4600010A (en) * 1984-10-04 1986-07-15 Biolectron, Inc. Electric stimulator and test instrument therefor
US5014699A (en) * 1986-05-23 1991-05-14 Trustees Of The University Of Pennsylvania Electromagnetic method and apparatus for healing living tissue
US5038797A (en) * 1990-02-20 1991-08-13 Romaine, Incorporated Electrical stimulation treatment device and method of use
US5273033A (en) * 1991-09-19 1993-12-28 Murray Electronics Associates Limited Partnership Electrical stimulation for treatment of osteoarthritis
US5338286A (en) * 1992-12-08 1994-08-16 Electro-Biology, Inc. Electromagnetic bioresponse by selective spectral suppression in pulsed field stimulation
US5374283A (en) * 1993-12-01 1994-12-20 Flick; A. Bart Electrical therapeutic apparatus
US6261221B1 (en) * 1996-11-01 2001-07-17 Amei Technologies Inc. Flexible coil pulsed electromagnetic field (PEMF) stimulation therapy system
US5743844A (en) * 1996-11-01 1998-04-28 Amei Technologies, Inc. High efficiency pulsed electromagnetic field (PEMF) stimulation therapy method and system
US6132362A (en) * 1996-11-01 2000-10-17 Amei Technologies, Inc. Pulsed electromagnetic field (PEMF) stimulation therapy system with bi-phasic coil
US5968527A (en) * 1997-02-27 1999-10-19 Catholic University Of America, The Protection of living systems from the adverse effects of stress
US6083149A (en) * 1997-10-22 2000-07-04 Emf Therapeutics, Inc. Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals
US6186940B1 (en) * 1998-05-18 2001-02-13 Robert N. Kirschbaum Energized trace elements
US7465566B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US6485963B1 (en) * 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof

Also Published As

Publication number Publication date
EP1575475A4 (en) 2007-10-10
NO20052254D0 (no) 2005-05-06
JP2006501853A (ja) 2006-01-19
KR20050056233A (ko) 2005-06-14
EP1575475A2 (en) 2005-09-21
ZA200503422B (en) 2006-12-27
CR7789A (es) 2005-10-05
ES2593307T3 (es) 2016-12-07
CN1703184A (zh) 2005-11-30
NZ539833A (en) 2008-08-29
US6919205B2 (en) 2005-07-19
WO2004033644A3 (en) 2004-09-23
WO2004033644A2 (en) 2004-04-22
EG23918A (en) 2007-12-30
AU2003279184A1 (en) 2004-05-04
CA2501554C (en) 2014-08-05
MXPA05003785A (es) 2005-09-20
EP1575475B1 (en) 2016-06-29
CA2501554A1 (en) 2004-04-22
US20040073260A1 (en) 2004-04-15
BR0315241A (pt) 2005-08-23

Similar Documents

Publication Publication Date Title
NO20052254L (no) Regulering av type II collagen-genekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler
NO20051947L (no) Regulering av aggrecan genekspresjonen ved bruk av spesifikk og selektiv elektriske og elektromagnetiske signaler
NO20060193L (no) Regulering av matriksmetallproteinasegenekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler
NO20063444L (no) System og metode for oppregulering av benmorfogenetisk proteingenekspresjon i benceller ved anvendelse av felt generert av spesifikke og selektive elektriske og elektromagnetiske signaler
Orapiriyakul et al. Nanovibrational stimulation of mesenchymal stem cells induces therapeutic reactive oxygen species and inflammation for three-dimensional bone tissue engineering
Mellor et al. Dynamic regulation of auxin oxidase and conjugating enzymes AtDAO1 and GH3 modulates auxin homeostasis
KR101248668B1 (ko) 저온 상압 플라즈마 노출을 이용한 세포의 생장 조절 방법
NO20085399L (no) Regulering av genekspresjon av transformerende vekstfaktor-beta (TGF-β) i levende celler via anvendelse av spesifikke og selektive elektriske og magnetiske felter
DE60139926D1 (de) Methode oder apparat zur kultivierung von zellen oder gewebe
Letelier et al. The Shh/Gli3 gene regulatory network precedes the origin of paired fins and reveals the deep homology between distal fins and digits
DE50013093D1 (de) Sequenz-spezifische dna-rekombination in eukaryotischen zellen
Tuli et al. p38 MAP kinase regulation of AP‐2 binding in TGF‐β1‐stimulated chondrogenesis of human trabecular bone‐derived cells
Kosmoski et al. DNA repair of a single UV photoproduct in a designed nucleosome
Salem Biological networks: An introductory review
Xiujuan et al. Effects of sound stimulation on protective enzyme activities and peroxidase isoenzymes of chrysanthemum
Milazzo et al. Stimulation of benzyladenine-induced in vitro shoot organogenesis and endogenous proline in melon (Cucumis melo L.) by fish protein hydrolysates in combination with proline analogues
Duggal et al. Promising Preliminary Activity of Optimized Affinity, CD38 CAR NK Cells Generated Using a Non-Viral Engineering Approach in Gene Edited Cord Blood Derived NK Cells for the Treatment of Multiple Myeloma
Zhadan et al. Impact of water consumption on efficiency of methane fermentation of chicken manure
ATE264387T1 (de) Verfahren zur auslösung von apoptose in zellen
Myakisheva et al. Peptides of cartilage tissue: regulation of chondrocyte proliferation, geroprotection and prospects for use in osteoarthrosis
Cruz et al. Investigating the Impact of Piezo1 Deletion in Smooth Muscle Cells on Intestinal Function
Lari et al. The evolution of human populations. The storytelling from the genome
Higgins et al. 815 Genetic architecture of linear localized scleroderma
Ullström et al. Significance of modulated adaptation for rhythm generation and inter-segmental co-ordination in lamprey
Choi Isolation and Characterization of UV-inducible gene in Eukaryotic cells

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application